Intraventricular treatment of relapsed and refractory central nervous system (CNS) lymphoma with rituximab.

被引：0
|
作者：
Schulz, H
Pels, H
Hom, E
Thall, A
Engert, A
机构：
[1] Univ Cologne, Clin Internal Med 1, Cologne, Germany
[2] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany
[3] Idec Pharmaceut Corp, Clin Immunol, San Diego, CA USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4725
引用
收藏
页码：249B / 249B
页数：1
相关论文
共 50 条
  • [31] Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study
    Reiss, Samantha N.
    Yerram, Prakirthi
    Modelevsky, Lisa
    Grommes, Christian
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 627 - 632
  • [32] Successful use of intraventricular and intravenous rituximab therapy for refractory primary CNS lymphoma in a child
    Akyuz, Canan
    Aydin, G. Burca
    Cila, Aysenur
    Akalan, Nejat
    Soylemezoglu, Figen
    Cengiz, Mustafa
    Yazici, Nalan
    Buyukpamukcu, Munevver
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (06) : 1253 - 1255
  • [33] Lenalidomide in the treatment of relapsed primary central nervous system lymphoma (PCNSL).
    Houillier, Caroline
    Choquet, Sylvain
    Touitou, Valerie
    Martin-Duverneuil, Nadine
    Khe Hoang-Xuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
    Murakami, Mineko
    Fujimaki, Takamitsu
    Asano, Shuichiro
    Nakaguchi, Hiroshi
    Yamada, Shoko M.
    Hoya, Katsumi
    Yamazaki, Kazuto
    Ishida, Yasuo
    Matsuno, Akira
    [J]. YONSEI MEDICAL JOURNAL, 2011, 52 (06) : 1031 - 1034
  • [35] LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
    Houillier, C.
    Choquet, S.
    Touitou, V.
    Martin-Duverneuil, N.
    Hoang-Xuan, K.
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [36] Application of new targeted drugs in relapsed/refractory primary central nervous system lymphoma
    Zhou, Ying
    Xu, Xiaohong
    [J]. HEMATOLOGY, 2022, 27 (01) : 105 - 112
  • [37] Zanubrutinib plus Cytarabine in Patients with Refractory/Relapsed Primary Central Nervous System Lymphoma
    Lin, Zhiguang
    Ma, Jingjing
    Ma, Yan
    Li, Qing
    Kang, Hui
    Zhang, Mengxue
    Chen, Bobin
    [J]. ACTA HAEMATOLOGICA, 2024,
  • [38] Efficacy of ocaratuzumab (AME-133v) in relapsed follicular lymphoma patients refractory to prior rituximab.
    Wayne, Jennifer L.
    Ganjoo, Kristen N.
    Pohlman, Brad L.
    De Vos, Sven
    Flinn, Ian W.
    Dang, Nam H.
    Mapara, Markus Y.
    Smith, Mitchell R.
    O'Reilly, Adrienne M.
    Marulappa, Shashidhara Y.
    Jain, Vinay Kumar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] A Case of Intraventricular Primary Central Nervous System Lymphoma
    Funaro, Kimberly
    Bailey, Katie C.
    Aguila, Sadie
    Agosti, Steven J.
    Vaillancourt, Christopher
    [J]. JOURNAL OF RADIOLOGY CASE REPORTS, 2014, 8 (03): : 1 - 8
  • [40] Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma
    Doolittle, Nancy D.
    Jahnke, Kristoph
    Belanger, Richard
    Ryan, Deborah A.
    Nance, Robert W., Jr.
    Lacy, Cynthia A.
    Tyson, Rose Marie
    Haluska, Marianne
    Hedrick, Nancy A.
    Varallyay, Csanad
    Neuwelt, Edward A.
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (09) : 1712 - 1720
12345